Jonathan Houssian, CEO and founder of RxElite, said: “This investment by NPIL Pharma will allow us to maintain our strong momentum in our Sevoflurane business through continued investment in anesthetic vaporizers and implementation of key customer contracts.”
RxElite develops, manufactures and markets generic prescription drug products in specialty generic markets.